New incident report
Incident Report Number: 2013-4501
Registrant Reference Number: 2013AM244
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 77 Belfield Rd
City: Toronto
Prov / State: ON
Country: Canada
Postal Code: M9W 1G6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556
Product Name: K9 Advantix II (unknown size)
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Dachshund
1
Male
12.5
Unknown
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Unknown / Inconnu
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On approximately 01-Jan-2012, a 12.5 year old, male, Dachshund canine, in poor condition, with concurrent diabetes and hyperadrenocorticism, was administered 1 tube of K9 Advantix II (unspecified) (Imidacloprid-Permethrin-Pyriproxyfen) once topically by the owner. The dog was on a regular treatment regimen with an unspecified brand of insulin. On an unknown date post administration the dog passed away from complications with diabetes. No necropsy was performed. The owner initially contacted Bayer Animal Health to seek advise on using product with a new pet and not to report the death of this pet.
Death
Death not expected in dog after product application, as inconsistent with pharmaco-toxicological product profile. Limited information (time to onset unknown - necropsy not available) as the intent of the phone call to Bayer was to seek advice on using product with a new pet, and not to report the death of the patient. Other etiologies more probable. Preexisting diabetes seemed to have caused death. No signs of allergy/anaphylactic reaction reported. Even though time to onset unknown, occurrence of sign within window of allergic/anaphylactic reaction (within 1 day) unlikely, as would have been reported in close proximity. Considering all aspects, product connection deemed to be unlikely.